CNS pipeline · person

Shashank Deshpande

Chairman of the Board of Managing Directors of Boehringer Ingelheim, effective 1 July 2025, taking over the chairman's mandate from Hubertus von Baumbach. He continues to lead the company's Human Pharma business unit.

  • 1 company

Current roles

Appears with

People sharing a company with Shashank.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.